Cargando…

No evidence for increased cell entry or antibody evasion by Delta sublineage AY.4.2

Since the beginning of the COVID-19 pandemic, multiple SARS-CoV-2 variants have emerged. While some variants spread only locally, others, referred to as variants of concern, disseminated globally and became drivers of the pandemic. All SARS-CoV-2 variants harbor mutations relative to the virus circu...

Descripción completa

Detalles Bibliográficos
Autores principales: Arora, Prerna, Kempf, Amy, Nehlmeier, Inga, Graichen, Luise, Winkler, Martin S., Lier, Martin, Schulz, Sebastian, Jäck, Hans-Martin, Pöhlmann, Stefan, Hoffmann, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727238/
https://www.ncbi.nlm.nih.gov/pubmed/34983951
http://dx.doi.org/10.1038/s41423-021-00811-8
_version_ 1784626477303595008
author Arora, Prerna
Kempf, Amy
Nehlmeier, Inga
Graichen, Luise
Winkler, Martin S.
Lier, Martin
Schulz, Sebastian
Jäck, Hans-Martin
Pöhlmann, Stefan
Hoffmann, Markus
author_facet Arora, Prerna
Kempf, Amy
Nehlmeier, Inga
Graichen, Luise
Winkler, Martin S.
Lier, Martin
Schulz, Sebastian
Jäck, Hans-Martin
Pöhlmann, Stefan
Hoffmann, Markus
author_sort Arora, Prerna
collection PubMed
description Since the beginning of the COVID-19 pandemic, multiple SARS-CoV-2 variants have emerged. While some variants spread only locally, others, referred to as variants of concern, disseminated globally and became drivers of the pandemic. All SARS-CoV-2 variants harbor mutations relative to the virus circulating early in the pandemic, and mutations in the viral spike (S) protein are considered of particular relevance since the S protein mediates host cell entry and constitutes the key target of the neutralizing antibody response. As a consequence, mutations in the S protein may increase SARS-CoV-2 infectivity and enable its evasion of neutralizing antibodies. Furthermore, mutations in the S protein can modulate viral transmissibility and pathogenicity.
format Online
Article
Text
id pubmed-8727238
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-87272382022-01-05 No evidence for increased cell entry or antibody evasion by Delta sublineage AY.4.2 Arora, Prerna Kempf, Amy Nehlmeier, Inga Graichen, Luise Winkler, Martin S. Lier, Martin Schulz, Sebastian Jäck, Hans-Martin Pöhlmann, Stefan Hoffmann, Markus Cell Mol Immunol Correspondence Since the beginning of the COVID-19 pandemic, multiple SARS-CoV-2 variants have emerged. While some variants spread only locally, others, referred to as variants of concern, disseminated globally and became drivers of the pandemic. All SARS-CoV-2 variants harbor mutations relative to the virus circulating early in the pandemic, and mutations in the viral spike (S) protein are considered of particular relevance since the S protein mediates host cell entry and constitutes the key target of the neutralizing antibody response. As a consequence, mutations in the S protein may increase SARS-CoV-2 infectivity and enable its evasion of neutralizing antibodies. Furthermore, mutations in the S protein can modulate viral transmissibility and pathogenicity. Nature Publishing Group UK 2022-01-05 2022-03 /pmc/articles/PMC8727238/ /pubmed/34983951 http://dx.doi.org/10.1038/s41423-021-00811-8 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Correspondence
Arora, Prerna
Kempf, Amy
Nehlmeier, Inga
Graichen, Luise
Winkler, Martin S.
Lier, Martin
Schulz, Sebastian
Jäck, Hans-Martin
Pöhlmann, Stefan
Hoffmann, Markus
No evidence for increased cell entry or antibody evasion by Delta sublineage AY.4.2
title No evidence for increased cell entry or antibody evasion by Delta sublineage AY.4.2
title_full No evidence for increased cell entry or antibody evasion by Delta sublineage AY.4.2
title_fullStr No evidence for increased cell entry or antibody evasion by Delta sublineage AY.4.2
title_full_unstemmed No evidence for increased cell entry or antibody evasion by Delta sublineage AY.4.2
title_short No evidence for increased cell entry or antibody evasion by Delta sublineage AY.4.2
title_sort no evidence for increased cell entry or antibody evasion by delta sublineage ay.4.2
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727238/
https://www.ncbi.nlm.nih.gov/pubmed/34983951
http://dx.doi.org/10.1038/s41423-021-00811-8
work_keys_str_mv AT aroraprerna noevidenceforincreasedcellentryorantibodyevasionbydeltasublineageay42
AT kempfamy noevidenceforincreasedcellentryorantibodyevasionbydeltasublineageay42
AT nehlmeieringa noevidenceforincreasedcellentryorantibodyevasionbydeltasublineageay42
AT graichenluise noevidenceforincreasedcellentryorantibodyevasionbydeltasublineageay42
AT winklermartins noevidenceforincreasedcellentryorantibodyevasionbydeltasublineageay42
AT liermartin noevidenceforincreasedcellentryorantibodyevasionbydeltasublineageay42
AT schulzsebastian noevidenceforincreasedcellentryorantibodyevasionbydeltasublineageay42
AT jackhansmartin noevidenceforincreasedcellentryorantibodyevasionbydeltasublineageay42
AT pohlmannstefan noevidenceforincreasedcellentryorantibodyevasionbydeltasublineageay42
AT hoffmannmarkus noevidenceforincreasedcellentryorantibodyevasionbydeltasublineageay42